A share price of Opus Genetics Inc [IRD] is currently trading at $1.09, up 9.60%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IRD shares have gain 6.86% over the last week, with a monthly amount glided 16.20%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Opus Genetics Inc [NASDAQ: IRD] stock has seen the most recent analyst activity on April 11, 2025, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $6.
Opus Genetics Inc experienced fluctuations in its stock price throughout the past year between $0.65 and $2.18. Opus Genetics Inc [NASDAQ: IRD] shares were valued at $1.09 at the most recent close of the market.
Analyzing the IRD fundamentals
Trailing Twelve Months sales for Opus Genetics Inc [NASDAQ:IRD] were 13.65M which represents 155.41% growth. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -5.65%, Pretax Profit Margin comes in at -5.23%, and Net Profit Margin reading is -5.23%. To continue investigating profitability, this company’s Return on Assets is posted at -1.56, Equity is -1.8 and Total Capital is -2.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8433 points at the first support level, and at 0.5967 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5433, and for the 2nd resistance point, it is at 1.9967.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Opus Genetics Inc [NASDAQ:IRD] is 1.98. As well, the Quick Ratio is 1.98, while the Cash Ratio is 2.68. Considering the valuation of this stock, the price to sales ratio is 4.76, the price to book ratio is 9.77.
Transactions by insiders
Recent insider trading involved Magrath George, Chief Executive Officer, that happened on Dec 26 ’24 when 100000.0 shares were purchased. President, YERXA BENJAMIN R completed a deal on Nov 21 ’24 to buy 10000.0 shares. Meanwhile, Chief Executive Officer Magrath George bought 90294.0 shares on Nov 15 ’24.
